An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging - Tabular View

Tracking Information

First Received Date ^ICMJE

June 25, 2007

Last Updated Date

December 18, 2007

Start Date ^ICMJE

June 2007

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00492479 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

An Evaluation of Kinerase Pro+Therapy Regimen Vs. Kinerase Vs. Control for the Treatment of Skin Aging

Official Title ^ICMJE

Brief Summary

The purpose of this study is to compare the efficacy of the Kinerase Pro+Therapy regimen versus a single Kinerase product vs. control for the treatment of the signs of skin aging.

Detailed Description

Study Phase

Phase IV

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Randomized, Single Blind, Active Control, Parallel Assignment

Condition ^ICMJE

Skin Aging

Intervention ^ICMJE

Drug: Kinerase Pro+Therapy Line day repair, serum, night repair
Drug: Kinerase Pro+Therapy Line Ultra rich day repair
Drug: LubriDerm

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Terminated

Enrollment ^ICMJE

Completion Date

December 2007

Primary Completion Date

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Female patients 35-55 years of age with at least moderate signs of facial aging
Written informed consent
Likely to complete all study visits and follow study protocol

Exclusion Criteria:

Any dermatological or medical condition which would make patient participation unsafe or interfere with study outcomes or measurements
Known hypersensitivity to any study product or their components
Recent (within 4 weeks of baseline) surgical treatment to face (including IPL and other laser procedures)
Prior use of anti-aging treatments for 30 days prior to study entry (physician dispensed or prescribed treatments)
Planned facial procedures during the study (microdermabrasion, facials, etc)

o Botox and fillers cannot be used during the trial or for 3 months prior to study entry
Recent (within 60 days) or concurrent participation in another clinical trial
Concomitant topical or systemic therapy that my interfere with study measurements or outcomes
Use of any other topical photoaging/antiaging therapies during the study, other than the prescribed study regimens
Patients who are habitual tanners (outdoors or with tanning beds) who plan on tanning during the study
Wearing of cosmetics during study visits

Gender

Female

Ages

35 Years to 55 Years

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00492479

Responsible Party

Study ID Numbers ^ICMJE

5314

Study Sponsor ^ICMJE

Innovative Medical

Collaborators ^ICMJE

Investigators ^ICMJE

Principal Investigator:

Steven Yoelin, MD

Private Practice

Information Provided By

Innovative Medical

Verification Date

December 2007

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP